Lucid Diagnostics
LUCD· Manufacturing· Fiscal year ends in December
CEO pay in FY2025Stock +33.1% in FY2025
Lishan Aklog, M.D. is the CEO of Lucid Diagnostics and was paid $897.0K in FY2025 (Dec), up 26%.
Pay$100 in the stock at the end of FY21 → $20
Executives4
See all- 1Lishan Aklog, M.D.Chairman of the Board and Chief Executive OfficerFY2025
- 2Shaun M. O’NeilPresident and Chief Operating OfficerFY2025
- 3Michael A. GordonGeneral Counsel and Corporate SecretaryFY2025
- 4Dennis M. McGrathChief Financial OfficerFY2025
Named executives and their total pay, from the Summary Compensation Table of the latest proxy.
Pay
See allLucid Diagnostics paid its 4 named executives $3.2M in total in FY2025 (Dec). CEO Lishan Aklog, M.D. was paid $897.0K of that.
| Name | |||
|---|---|---|---|
| Lishan Aklog, M.D.Chairman of the Board and Chief Executive Officer | |||
| Shaun M. O’NeilPresident and Chief Operating Officer | |||
| Michael A. GordonGeneral Counsel and Corporate Secretary | |||
| Dennis M. McGrathChief Financial Officer |
of each named executive, from the Summary Compensation Table of each proxy.
Peers
No disclosed peer group
No proxy on file names a pay peer group for Lucid Diagnostics. The peer group comes from the proxy statement, so it shows here when a proxy read has it.
Board1
See all- Debra J. WhiteDirector · 3 yr on the boardIndependentAudit, Nominating and Corporate Governance—Paid as an executive
The board of the latest proxy (FY2025).
Activity
Filings6
See all| Proxy statement | DEF 14A | Apr 30, 2026 | FY2025 |
| Annual report | 10-K | Mar 25, 2026 | FY2025 |
| Proxy statement | DEF 14A | Apr 30, 2025 | FY2024 |
| Annual report | 10-K | Mar 24, 2025 | FY2024 |
| Proxy statement | DEF 14A | Apr 29, 2024 | FY2023 |
| Annual report | 10-K | Mar 25, 2024 | FY2023 |
